Cargando…

One-week vaginal brachytherapy schedule as exclusive adjuvant post-operative treatment in intermediate- and high-intermediate-risk endometrial cancer patients

PURPOSE: The aim of the study was to report survival outcomes and toxicities incidence by using one-week vaginal brachytherapy (VBT) schedule in intermediate- and high-intermediate-risk endometrial cancer patients. MATERIAL AND METHODS: One hundred and eight patients were treated with exclusive high...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Sanctis, Vitaliana, Musio, Daniela, De Felice, Francesca, Marampon, Francesco, Valeriani, Maurizio, Bonome, Paolo, Anzellini, Dimitri, Facondo, Giuseppe, Vullo, Gianluca, Massaro, Maria, Di Staso, Mario, Bonfili, Pierluigi, Chalaszczyk, Agnieszka, Gravina, Giovanni Luca, Tombolini, Vincenzo, Osti, Mattia Falchetto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2020
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207237/ https://www.ncbi.nlm.nih.gov/pubmed/32395136 http://dx.doi.org/10.5114/jcb.2020.94581

Ejemplares similares

Hypofractionated Radiotherapy in Intermediate-Risk Prostate Cancer Patients: Long-Term Results
por: Valeriani, Maurizio, et al.
Publicado: (2022)

Quality of life and sexual functioning among endometrial cancer patients treated with one week adjuvant high-dose-rate vaginal brachytherapy schedule
por: Facondo, Giuseppe, et al.
Publicado: (2022)

Clinical Outcomes of Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Patients with Lymph Node Metastases from Gynecological Cancers
por: Facondo, Giuseppe, et al.
Publicado: (2023)

Androgen Receptor Targeted Therapy + Radiotherapy in Metastatic Castration Resistant Prostate Cancer
por: Massaro, Maria, et al.
Publicado: (2021)

Intermediate-risk prostate cancer patients treated with androgen deprivation therapy and a hypofractionated radiation regimen with or without image guided radiotherapy
por: Valeriani, Maurizio, et al.
Publicado: (2013)

Re-irradiation in lung disease by SBRT: a retrospective, single institutional study
por: Caivano, Donatella, et al.
Publicado: (2018)

Stereotactic body radiation therapy for the treatment of lymph node metastases: a retrospective mono-institutional study in a large cohort of patients
por: Caivano, Donatella, et al.
Publicado: (2023)

The role of vaginal brachytherapy in stage I endometrial serous cancer: a systematic review
por: Lancellotta, Valentina, et al.
Publicado: (2020)

Different outcomes among favourable and unfavourable intermediate-risk prostate cancer patients treated with hypofractionated radiotherapy and androgen deprivation therapy
por: Bracci, Stefano, et al.
Publicado: (2016)

Comparative analysis of toxicity in patients with anal cancer undergoing definitive simultaneous integrated boost (SIB) or sequential integrated boost (SeqB) radiotherapy
por: Rotondi, Margherita, et al.
Publicado: (2023)

Efficacy of Residual Site Radiation Therapy (ISRT) in Patients with Primary Mediastinal Lymphoma with Deauville Score 4 Following R-CHT: Results of a Retrospective Mono Institutional Study
por: Facondo, Giuseppe, et al.
Publicado: (2023)

Adjuvant radiation therapy in stage I seminoma: 20 years of oncologic results
por: De Felice, Francesca, et al.
Publicado: (2016)

Image guided intensity modulated hypofractionated radiotherapy in high-risk prostate cancer patients treated four or five times per week: analysis of toxicity and preliminary results
por: Valeriani, Maurizio, et al.
Publicado: (2014)

Treatment of Solitary Painful Osseous Metastases with Radiotherapy, Cryoablation or Combined Therapy: Propensity Matching Analysis in 175 Patients
por: Di Staso, Mario, et al.
Publicado: (2015)

Radiation therapy and serum salivary amylase in head and neck cancer
por: De Felice, Francesca, et al.
Publicado: (2017)

Image-Guided Hypofractionated Radiotherapy in Low-Risk Prostate Cancer Patients
por: Valeriani, Maurizio, et al.
Publicado: (2014)

Local and metastatic curative radiotherapy in patients with de novo oligometastatic prostate cancer
por: Reverberi, C., et al.
Publicado: (2020)

Radiotherapy in metastatic castration resistant prostate cancer patients with oligo-progression during abiraterone-enzalutamide treatment: a mono-institutional experience
por: Valeriani, Maurizio, et al.
Publicado: (2019)

Adjuvant vaginal interventional radiotherapy in early-stage non-endometrioid carcinoma of corpus uteri: a systematic review
por: De Felice, Francesca, et al.
Publicado: (2021)

Fractionated stereotactic radiosurgery for patients with skull base metastases from systemic cancer involving the anterior visual pathway
por: Minniti, Giuseppe, et al.
Publicado: (2014)

Long term results of single high dose Stereotactic Body Radiotherapy in the treatment of primary lung tumors
por: Nicosia, Luca, et al.
Publicado: (2019)

Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group
por: Reboux, Pierre-Alain, et al.
Publicado: (2019)

Skin metastases from prostate cancer successfully treated with radiation therapy
por: Marampon, Francesco, et al.
Publicado: (2023)

Orbital Radiotherapy Plus Concomitant Steroids in Moderate-to-Severe Graves’ Ophthalmopathy: Good Results After Long-Term Follow-Up
por: Nicosia, Luca, et al.
Publicado: (2019)

Treatment in locally advanced rectal cancer: a machine learning bibliometric analysis
por: De Felice, Francesca, et al.
Publicado: (2021)

Head and neck cancer: metronomic chemotherapy
por: De Felice, Francesca, et al.
Publicado: (2015)

Weekly hypofractionated radiation therapy in elderly non-resectable cutaneous squamous cell carcinoma of the head and neck region
por: De Felice, Francesca, et al.
Publicado: (2020)

Immune Check-Point Inhibitors and Standard Chemoradiotherapy in Definitive Head and Neck Cancer Treatment
por: De Felice, Francesca, et al.
Publicado: (2021)

Stratification of brachytherapy-treated intermediate-risk prostate cancer patients into favorable and unfavorable cohorts
por: Merrick, Gregory S., et al.
Publicado: (2015)

Focal low-dose-rate prostate brachytherapy for low- and intermediate-risk prostate cancer
por: Kunogi, Hiroaki, et al.
Publicado: (2020)

Strategies for Imaging Androgen Receptor Signaling Pathway in Prostate Cancer: Implications for Hormonal Manipulation and Radiation Treatment
por: Giovanni Luca, Gravina, et al.
Publicado: (2013)

Erratum to “Strategies for Imaging Androgen Receptor Signaling Pathway in Prostate Cancer: Implications for Hormonal Manipulation and Radiation Treatment”
por: Gravina, Giovanni L., et al.
Publicado: (2014)

Scheduling management and optimization analysis of intermediate products transfer in a shipyard for cruise ships
por: Liu, Jiajie, et al.
Publicado: (2022)

Safety and efficacy of combining afatinib and whole-brain radiation therapy in treating brain metastases from EGFR-mutated NSCLC: a case report and literature review
por: Marampon, Francesco, et al.
Publicado: (2022)

Combined external beam radiotherapy and vaginal brachytherapy versus vaginal brachytherapy in stage I, intermediate- and high-risk cases of endometrium carcinoma
por: Sunil, R.A., et al.
Publicado: (2018)

Clinical outcomes of low-dose-rate brachytherapy based radiotherapy for intermediate risk prostate cancer
por: Okamoto, Keisei, et al.
Publicado: (2020)

Comparison of EBRT and I-125 seed brachytherapy concerning outcome in intermediate-risk prostate cancer
por: Moll, Matthias, et al.
Publicado: (2021)

Management of persistent anal canal carcinoma after combined-modality therapy: a clinical review
por: Musio, Daniela, et al.
Publicado: (2014)

The role of radiation therapy in bone metastases management
por: Felice, Francesca De, et al.
Publicado: (2017)

Ten‐step method of high‐dose LDR (125)I brachytherapy for intermediate‐risk prostate cancer
por: Okamoto, Keisei
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_obshodnue1flh3p673qkobspmd